Treatment of experimental anterior and intermediate uveitis by a dexamethasone intravitreal implant.
about
Evaluation of a prednisolone acetate-loaded subconjunctival implant for the treatment of recurrent uveitis in a rabbit modelIntravitreal dexamethasone implant in patients with persistent diabetic macular edema.Species Differences in the Geometry of the Anterior Segment Differentially Affect Anterior Chamber Cell Scoring Systems in Laboratory Animals.Surgical management in patient with uveitis.Wandering Ozurdex(®) implant.Dexamethasone intravitreal implant for the treatment of noninfectious uveitis.The Sustained-Release Dexamethasone Implant: Expanding Indications in Vitreoretinal Disease.Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis.Effect of a Soluble Epoxide Hydrolase Inhibitor, UC1728, on LPS-Induced Uveitis in the Rabbit.Experimental uveitis can be maintained in rabbits for a period of six weeks after a safe sensitization method.Treatment of immune-mediated keratitis in horses with episcleral silicone matrix cyclosporine delivery devices.Ocular Drug Distribution and Safety of a Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in Rabbit.Intravitreal Adalimumab for the Control of Breakthrough Intraocular Inflammation.Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in the Treatment of Experimental Uveitis Rabbit.Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.Dexamethasone intravitreal implant: an effective adjunctive treatment for recalcitrant noninfectious uveitis.Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis.
P2860
Q33633008-B2364E59-0480-4D83-9DB4-9CBDFA2B3280Q34152161-760BE267-F37B-458C-852A-A3033ECA9B3AQ36549228-F18C3218-B97E-4997-914E-43335804139AQ37098310-0AEE3524-63CF-4E01-AB2B-9E8EB5D9B1A0Q37940886-1A989EE6-2DC0-4AFD-946D-3C3517A08D71Q37964659-39B7649B-DF0F-4CBA-8229-BE6785202104Q38198098-82189F2E-3793-4C40-9AB9-24759B4CA15AQ38843440-80B599D8-6EE1-4909-A553-3A95918F5767Q40919250-F31DF146-8C84-41F7-8F05-4A0573599A86Q44436609-AA9116DF-7683-48E5-9007-4B35B02CB0BFQ44869053-2F133528-9F0D-4B23-B8BB-8C249D381294Q50047501-823780A3-D4DF-43B7-84B9-78DACC114F0CQ50091416-515C75B7-FC04-4E8D-9033-16B6ECDF280CQ50097437-9DCBBE48-91AF-4C75-BD0B-22F1999FA3F3Q53558849-E7E049C1-276A-4FD0-8A7A-27962BD121C6Q53793193-393A5138-E426-4784-9F75-B2D6503C627EQ55176472-F4128FA3-E89C-46ED-AD51-9C1D18FE92A1
P2860
Treatment of experimental anterior and intermediate uveitis by a dexamethasone intravitreal implant.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Treatment of experimental ante ...... ethasone intravitreal implant.
@en
Treatment of experimental ante ...... ethasone intravitreal implant.
@nl
type
label
Treatment of experimental ante ...... ethasone intravitreal implant.
@en
Treatment of experimental ante ...... ethasone intravitreal implant.
@nl
prefLabel
Treatment of experimental ante ...... ethasone intravitreal implant.
@en
Treatment of experimental ante ...... ethasone intravitreal implant.
@nl
P2093
P356
P1476
Treatment of experimental ante ...... ethasone intravitreal implant.
@en
P2093
Corine R Ghosn
James A Burke
Larry Wheeler
Michael R Robinson
Werhner C Orilla
P304
P356
10.1167/IOVS.10-5939
P407
P577
2011-05-02T00:00:00Z